PSI-697 P-Selectin Inhibitor,99.73%

产品编号:Bellancom-15526| CAS NO:851546-61-7| 分子式:C21H18ClNO3| 分子量:367.83

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-15526
1400.00 杭州 北京(现货)
Bellancom-15526
3500.00 杭州 北京(现货)
Bellancom-15526
5000.00 杭州 北京(现货)
Bellancom-15526
15000.00 杭州 北京(现货)
Bellancom-15526
21000.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

PSI-697 P-Selectin Inhibitor

产品介绍 PSI-697 是一种口服的 P-selectin 抑制剂,IC50 值为 125 μM。
生物活性

PSI-697 is an oral P-selectin inhibitor with an IC50 of 125 μM.

体外研究

PSI-697 inhibits the binding of a soluble human P-selectin to PSGL-1, in a reproducible concentration-dependent manner inhibiting 50% of binding at a concentration of 125 μM in vitro.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究

PSI-697 (0-50 mg/kg; p.o.) significantly reduces the number of rolling leukocytes by 39% versus vehicle control.
PSI-697 (100 mg/kg; p.o.) reduces thrombus weight by 18% relative to vehicle, without prolonging bleeding time in a rat venous thrombosis model.
PSI-697 (30 mg/kg; p.o.; daily; 6 days) promotes thrombus resolution and decreases inflammation in a baboon model of venous thrombosis.
PSI-697 ((30 mg/kg; i.g.; daily) decreases vein wall injury in a rat stenosis model of venous thrombosis.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 4-5 weeks male Sprague-Dawley rat (50-100 g)
Dosage: 0 mg/kg, 30 mg/kg, 50 mg/kg
Administration: Oral administration
Result: At an oral dose of 50 mg/kg reduced the number of rolling leukocytes by 39% versus vehicle control.
体内研究

PSI-697 (0-50 mg/kg; p.o.) significantly reduces the number of rolling leukocytes by 39% versus vehicle control.
PSI-697 (100 mg/kg; p.o.) reduces thrombus weight by 18% relative to vehicle, without prolonging bleeding time in a rat venous thrombosis model.
PSI-697 (30 mg/kg; p.o.; daily; 6 days) promotes thrombus resolution and decreases inflammation in a baboon model of venous thrombosis.
PSI-697 ((30 mg/kg; i.g.; daily) decreases vein wall injury in a rat stenosis model of venous thrombosis.

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: 4-5 weeks male Sprague-Dawley rat (50-100 g)
Dosage: 0 mg/kg, 30 mg/kg, 50 mg/kg
Administration: Oral administration
Result: At an oral dose of 50 mg/kg reduced the number of rolling leukocytes by 39% versus vehicle control.
性状Solid
溶解性数据
In Vitro: 

DMSO : ≥ 45.8 mg/mL (124.51 mM)

* "≥" means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 2.7186 mL 13.5932 mL 27.1865 mL
5 mM 0.5437 mL 2.7186 mL 5.4373 mL
10 mM 0.2719 mL 1.3593 mL 2.7186 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服